POB2 REDUCING GLOBAL CARDIOMETABOLIC RISK IN OVERWEIGHT OR OBESE INDIVIDUALS WITH DYSLIPIDEMIA: PROJECTED BENEFITS OF RIMONABANT IN A REAL WORLD POPULATION
D Getsios, J Moller, P McEwan, A Danel, KJ Ishak, JJ CaroVolume:
10
Year:
2007
Language:
english
DOI:
10.1016/s1098-3015(10)65592-1
File:
PDF, 76 KB
english, 2007